| Straus D Comparative studies on erythropoietic agents. [Journal Article] J Natl Compr Canc Netw 2005 Nov.:S46-9. Full Citation | Publisher Full Text | Find Related Articles |
| Steensma DP, Loprinzi CL Epoetin alfa and darbepoetin alfa go head to head. [Comment, Editorial] J Clin Oncol 2006 May 20; 24(15):2233-6. Full Citation | Publisher Full Text | Find Related Articles |
| Yang MC Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia. [Comment, Letter] Ann Pharmacother 2006 May; 40(5):998-9; author reply 999. Full Citation | Publisher Full Text | Find Related Articles |
| Longfield V, Gebhart B, Hayward L Development of a strategy to successfully convert an ambulatory infusion center from epoetin alfa to darbepoetin alfa. [Journal Article] J Support Oncol 2005 Nov-Dec; 3(6 Suppl 4):8-9. Full Citation | Find Related Articles |
| Zitella L Erythropoietin-stimulating agents: new data yield new insights. [Journal Article] Oncology (Williston Park) 2007 Oct; 21(11 Suppl Nurse Ed):36-8. Full Citation | Find Related Articles |
| Koopman W, Iakiri S Utilizing quality of life as a factor in treatment choices for chemotherapy-induced anemia. [Journal Article] J Support Oncol 2005 Nov-Dec; 3(6 Suppl 4):20-1. Full Citation | Find Related Articles |
| Case AS, Rocconi RP, Kilgore LC, et al. Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies. [Journal Article] Gynecol Oncol 2006 Jun; 101(3):499-502. Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Crawford J Erythropoietin: high profile, high scrutiny. [Comment, Editorial] J Clin Oncol 2007 Mar 20; 25(9):1021-3. Full Citation | Publisher Full Text | Find Related Articles |
| Steensma DP New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony. [Journal Article] J Support Oncol 2007 Nov-Dec; 5(10):471-3. Full Citation | Find Related Articles |
 |